MARKET

ETON

ETON

Eton Pharmaceuticals
NASDAQ
14.76
+0.41
+2.86%
After Hours: 14.76 0 0.00% 17:43 02/06 EST
OPEN
14.60
PREV CLOSE
14.35
HIGH
15.01
LOW
14.52
VOLUME
228.80K
TURNOVER
--
52 WEEK HIGH
23.00
52 WEEK LOW
11.09
MARKET CAP
395.83M
P/E (TTM)
-59.2295
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on These Healthcare Stocks: Eton Pharmaceuticals (ETON), HealthStream (HSTM)
TipRanks · 5d ago
Eton Pharmaceuticals Licenses U.S. Rights to Ultra-Rare Drug
TipRanks · 5d ago
Eton licenses U.S. marketing rights to ultra-rare disease product candidate
TipRanks · 6d ago
Eton Pharmaceuticals Plans 2026 Launch of FDA-Reviewed Ultra-Rare Disease Product, Expands Pipeline and Pursues Additional High-Value Opportunities
Reuters · 6d ago
Eton Pharma Announces Licensing Of U.S. Marketing Rights To Ultra-Rare Disease Product Candidate; Product Is Currently Under Review With FDA; Potential Approval And Launch Mid-2026
Benzinga · 6d ago
ETON PHARMACEUTICALS INC - POTENTIAL APPROVAL AND LAUNCH MID-2026
Reuters · 6d ago
Weekly Report: what happened at ETON last week (0126-0130)?
Weekly Report · 6d ago
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
Barchart · 6d ago
More
About ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.

Webull offers Eton Pharmaceuticals Inc stock information, including NASDAQ: ETON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ETON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ETON stock methods without spending real money on the virtual paper trading platform.